Role of oxidative stress in the pathogenesis of sickle cell disease

IUBMB Life

Volumn 64, Issue 1, 2012, Pages 72-80

  Chirico, Erica N ^a   Pialoux, Vincent ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

antioxidants; hemoglobin; nitric oxide; reactive oxygen species

Indexed keywords

ASCORBIC ACID; CAROTENOID; CATALASE; CYTOCHROME P450; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A; HEMOGLOBIN S; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INTERCELLULAR ADHESION MOLECULE 1; LIPOXYGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RIBOFLAVIN; SELENIUM; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; TOCOPHEROL; UBIQUINOL CYTOCHROME C REDUCTASE; URIC ACID; VASCULAR CELL ADHESION MOLECULE 1; XANTHINE OXIDASE; ZINC;

ANTIOXIDANT ACTIVITY; BIOAVAILABILITY; CELL ADHESION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ERYTHROCYTE; HEMOLYSIS; HUMAN; HYPOXIA; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REPERFUSION INJURY; RESPIRATORY CHAIN; REVIEW; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ANEMIA, SICKLE CELL; ANIMALS; ANTIOXIDANTS; CELL ADHESION; ERYTHROCYTES; HEMOLYSIS; HUMANS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 84855425858     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.584     Document Type: Review

References (65)

1. Stuart, M. J., and, Nagel, R. L., (2004) Sickle-cell disease. Lancet 364, 1343-1360. (Pubitemid 39335827)
2. Belcher, J. D., Beckman, J. D., Balla, G., Balla, J., and, Vercellotti, G., (2010) Heme degradation and vascular injury. Antioxid. Redox Signal 12, 233-248.
3. Kohen, R., and, Nyska, A., (2002) Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 30, 620-650. (Pubitemid 36018731)
4. Prabhakar, N. R., Kumar, G. K., Nanduri, J., and, Semenza, G. L., (2007) ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid. Redox Signal 9, 1397-1403. (Pubitemid 47255019)
5. Xu, W., Chi, L., Row, B. W., Xu, R., Ke, Y., et al. (2004) Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 126, 313-323. (Pubitemid 38780807)
6. Yuan, G., Adhikary, G., McCormick, A. A., Holcroft, J. J., Kumar, G. K., et al. (2004) Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells. J. Physiol. (Lond.) 557, 773-783. (Pubitemid 38961615)
7. Klings, E. S., and, Farber, H. W., (2001) Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir. Res. 2, 280-285. (Pubitemid 34189652)
8. Morris, C. R., Suh, J. H., Hagar, W., Larkin, S., Bland, D. A., et al. (2008) Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood 111, 402-410.
9. Uzunova, V. V., Pan, W., Galkin, O., and, Vekilov, P. G., (2010) Free heme and the polymerization of sickle cell hemoglobin. Biophys. J. 99, 1976-1985.
10. Bunn, H. F., Noguchi, C. T., Hofrichter, J., Schechter, G. P., Schechter, A. N., et al. (1982) Molecular and cellular pathogenesis of hemoglobin SC disease. Proc. Natl. Acad. Sci. USA 79, 7527-7531. (Pubitemid 13179140)
11. Aslan, M., Thornley-Brown, D., and, Freeman, B. A., (2000) Reactive species in sickle cell disease. Ann. N. Y. Acad. Sci. 899, 375-391. (Pubitemid 30352801)
12. Conran, N., Franco-Penteado, C. F., and, Costa, F. F., (2009) Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin 33, 1-16.
13. Wood, K. C., Hsu, L. L., and, Gladwin, M. T., (2008) Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic. Biol. Med 44, 1506-1528.
14. Hebbel, R. P., Morgan, W. T., Eaton, J. W., and, Hedlund, B. E., (1988) Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc. Natl. Acad. Sci. USA 85, 237-241. (Pubitemid 18055323)
15. Sheng, K., Shariff, M., and, Hebbel, R. P., (1998) Comparative oxidation of hemoglobins A and S. Blood 91, 3467-3470. (Pubitemid 28193900)
16. Amer, J., Ghoti, H., Rachmilewitz, E., Koren, A., Levin, C., et al. (2006) Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br. J. Haematol. 132, 108-113. (Pubitemid 43381577)
17. McCurdy, P. R., and, Sherman, A. S., (1978) Irreversibly sickled cells and red cell survival in sickle cell anemia: a study with both DF32P and 51CR. Am. J. Med. 64, 253-258. (Pubitemid 8287297)
18. Morris, C. R., Kuypers, F. A., Larkin, S., Sweeters, N., Simon, J., et al. (2000) Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. Br. J. Haematol. 111, 498-500.
19. Hebbel, R. P., (2011) Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine. Am. J. Hematol. 86, 123-154.
20. Reiter, C. D., and, Gladwin, M. T., (2003) An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr. Opin. Hematol. 10, 99-107. (Pubitemid 36207963)
21. Jeffers, A., Gladwin, M. T., and, Kim-Shapiro, D. B., (2006) Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias. Free Radic. Biol. Med. 41, 1557-1565. (Pubitemid 44550083)
22. Morris, C. R., Kato, G. J., Poljakovic, M., Wang, X., Blackwelder, W. C., et al. (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294, 81-90. (Pubitemid 41002842)
23. Gladwin, M. T., Schechter, A. N., Ognibene, F. P., Coles, W. A., Reiter, C. D., et al. (2003) Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation 107, 271-278. (Pubitemid 36135223)
24. Chen, K., Piknova, B., Pittman, R. N., Schechter, A. N., and, Popel, A. S., (2008) Nitric oxide from nitrite reduction by hemoglobin in the plasma and erythrocytes. Nitric Oxide 18, 47-60. (Pubitemid 350299198)
25. Wood, K. C., Hebbel, R. P., Lefer, D. J., and, Granger, D. N., (2006) Critical role of endothelial cell-derived nitric oxide synthase in sickle cell disease-induced microvascular dysfunction. Free Radic. Biol. Med. 40, 1443-1453.
26. Gilligan, D. M., Panza, J. A., Kilcoyne, C. M., Waclawiw, M. A., Casino, P. R., et al. (1994) Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 90, 2853-2858.
27. Vilas-Boas, W., Cerqueira, B. A. V., Zanette, A. M. D., Reis, M. G., Barral-Netto, M., et al. (2010) Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients. Ann. Hematol. 89, 877-882.
28. Kaul, D. K., Zhang, X., Dasgupta, T., and, Fabry, M. E., (2008) Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 295, H39-H47.
29. Dasgupta, T., Hebbel, R. P., and, Kaul, D. K., (2006) Protective effect of arginine on oxidative stress in transgenic sickle mouse models. Free Radic. Biol. Med. 41, 1771-1780. (Pubitemid 44839141)
30. Cosentino, F., and, Katusić, Z. S., (1995) Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91, 139-144.
31. Vásquez-Vivar, J., (2009) Tetrahydrobiopterin, superoxide, and vascular dysfunction. Free Radic. Biol. Med. 47, 1108-1119.
32. Cosentino, F., Hürlimann, D., Delli Gatti, C., Chenevard, R., Blau, N., et al. (2008) Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart 94, 487-492. (Pubitemid 351441407)
33. Kato, G. J., Martyr, S., Blackwelder, W. C., Nichols, J. S., Coles, W. A., et al. (2005) Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br. J. Haematol. 130, 943-953. (Pubitemid 43899735)
34. Space, S. L., Lane, P. A., Pickett, C. K., and, Weil, J. V., (2000) Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium. Am. J. Hematol. 63, 200-204. (Pubitemid 30165407)
35. Setty, B. N., and, Stuart, M. J., (1996) Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 88, 2311-2320. (Pubitemid 26307936)
36. Solovey, A. A., Solovey, A. N., Harkness, J., and, Hebbel, R. P., (2001) Modulation of endothelial cell activation in sickle cell disease: a pilot study. Blood 97, 1937-1941. (Pubitemid 32239070)
37. Sultana, C., Shen, Y., Rattan, V., Johnson, C., and, Kalra, V. K., (1998) Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood 92, 3924-3935. (Pubitemid 28525219)
38. Ikeda, M., Schroeder, K. K., Mosher, L. B., Woods, C. W., and, Akeson, A. L., (1994) Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes. J. Invest. Dermatol. 103, 791-796.
39. Marui, N., Offermann, M. K., Swerlick, R., Kunsch, C., Rosen, C. A., et al. (1993) Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92, 1866-1874. (Pubitemid 23304554)
40. Mahaseth, H., Vercellotti, G. M., Welch, T. E., Bowlin, P. R., Sonbol, K. M., et al. (2005) Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice. J. Lab. Clin. Med. 145, 204-211. (Pubitemid 40692403)
41. Roy, S., Sen, C. K., Kobuchi, H., and, Packer, L., (1998) Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells. Free Radic. Biol. Med. 25, 229-241. (Pubitemid 28293159)
42. Kalambur, V. S., Mahaseth, H., Bischof, J. C., Kielbik, M. C., Welch, T. E., et al. (2004) Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. Am. J. Hematol. 77, 117-125. (Pubitemid 39281854)
43. Pace, B. S., Shartava, A., Pack-Mabien, A., Mulekar, M., Ardia, A., et al. (2003) Effects of N-acetylcysteine on dense cell formation in sickle cell disease. Am. J. Hematol. 73, 26-32. (Pubitemid 36504574)
44. Osarogiagbon, U. R., Choong, S., Belcher, J. D., Vercellotti, G. M., Paller, M. S., et al. (2000) Reperfusion injury pathophysiology in sickle transgenic mice. Blood 96, 314-320. (Pubitemid 30456487)
45. Szocs, K., (2004) Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen. Physiol. Biophys. 23, 265-295. (Pubitemid 39485250)
46. Kanczler, J. M., Millar, T. M., Bodamyali, T., Blake, D. R., and, Stevens, C. R., (2003) Xanthine oxidase mediates cytokine-induced, but not hormone-induced bone resorption. Free Radic. Res. 37, 179-187. (Pubitemid 36124344)
47. Flanders, K. C., Bhandiwad, A. R., and, Winokur, T. S., (1997) Transforming growth factor-betas block cytokine induction of catalase and xanthine oxidase mRNA levels in cultured rat cardiac cells. J. Mol. Cell. Cardiol. 29, 273-280. (Pubitemid 27129151)
48. Lappas, M., Mitton, A., Mittion, A., and, Permezel, M., (2010) In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes. J. Endocrinol. 204, 75-84.
49. Aslan, M., and, Freeman, B. A., (2007) Redox-dependent impairment of vascular function in sickle cell disease. Free Radic. Biol. Med. 43, 1469-1483. (Pubitemid 47615401)
50. Taylor, C. T., and, Cummins, E. P., (2009) The role of NF-kappaB in hypoxia-induced gene expression. Ann. N. Y. Acad. Sci. 1177, 178-184.
51. Natta, C. L., Chen, L. C., and, Chow, C. K., (1990) Selenium and glutathione peroxidase levels in sickle cell anemia. Acta Haematol. 83, 130-132. (Pubitemid 20102958)
52. Manfredini, V., Lazzaretti, L. L., Griebeler, I. H., Santin, A. P., Brandão, V. D. M., et al. (2008) Blood antioxidant parameters in sickle cell anemia patients in steady state. J. Natl. Med. Assoc. 100, 897-902.
53. Das, S. K., and, Nair, R. C., (1980) Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Br. J. Haematol. 44, 87-92. (Pubitemid 10201711)
54. Schacter, L., Warth, J. A., Gordon, E. M., Prasad, A., and, Klein, B. L., (1988) Altered amount and activity of superoxide dismutase in sickle cell anemia. FASEB J. 2, 237-243. (Pubitemid 18067864)
55. Tatum, V. L., and, Chow, C. K., (1996) Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress. Free Radic. Res. 25, 133-139. (Pubitemid 26345343)
56. Nur, E., Biemond, B. J., Otten, H.-M., Brandjes, D. P., and, Schnog, J.-J. B., (2011) Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am. J. Hematol. 86, 484-489.
57. Chiu, D., Vichinsky, E., Yee, M., Kleman, K., and, Lubin, B., (1982) Peroxidation, vitamin E, and sickle-cell anemia. Ann. N. Y. Acad. Sci. 393, 323-335. (Pubitemid 13206921)
58. Natta, C. L., Machlin, L. J., and, Brin, M., (1980) A decrease in irreversibly sickled erythrocytes in sicle cell anemia patients given vitamin E. Am. J. Clin. Nutr. 33, 968-971. (Pubitemid 10040627)
59. Ohnishi, S. T., Ohnishi, T., and, Ogunmola, G. B., (2000) Sickle cell anemia: a potential nutritional approach for a molecular disease. Nutrition 16, 330-338. (Pubitemid 30227689)
60. Marangon, K., Devaraj, S., Tirosh, O., Packer, L., and, Jialal, I., (1999) Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress. Free Radic. Biol. Med. 27, 1114-1121. (Pubitemid 29507484)
61. Lexis, L. A., Fassett, R. G., and, Coombes, J. S., (2006) Alpha-tocopherol and alpha-lipoic acid enhance the erythrocyte antioxidant defence in cyclosporine A-treated rats. Basic Clin. Pharmacol. Toxicol. 98, 68-73.
62. Cartron, J.-P., and, Elion, J., (2008) Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transfus. Clin. Biol. 15, 39-50.
63. Gladwin, M. T., Shelhamer, J. H., Ognibene, F. P., Pease-Fye, M. E., Nichols, J. S., et al. (2002) Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br. J. Haematol. 116, 436-444. (Pubitemid 34155519)
64. Wood, K. C., Hebbel, R. P., and, Granger, D. N., (2005) Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice. FASEB J. 19, 989-991. (Pubitemid 40827727)
65. Kaul, D. K., Liu, X.-D., Choong, S., Belcher, J. D., Vercellotti, G. M., et al. (2004) Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am. J. Physiol. Heart Circ. Physiol. 287, H293-H301. (Pubitemid 38802365)